- Daimler Trucks hands over first all-electric FUSO eCanter trucks to customers
- Daimler launches new DENZA electric vehicle for the Chinese market
- Pride Tour 2018: Daimler supports tolerance and diversity worldwide
- Cortec® Introduces EcoShield® Super Barrier Paper and Linerboard
- Industry calls for urgent clarity on EU workers as survey shows recruitment crunch looming
- Rimac opens 100 new jobs
- Amey and Sersa, as part of the S&C North Alliance, win Infrastructure Achievement Award at National Rail Awards
- Covestro expands global capacity for polyurethane dispersions
Chemicals and Pharmaceuticals
Croda International Plc, the speciality chemical manufacturing company, has announced that it has acquired Nautilus Biosciences Canada Inc, a technology-rich marine biotechnology company based in Charlottetown, Prince Edward Island, Canada.
Clariant, a world leader in speciality chemicals, has announced that it has signed two key agreements with SINOPEC, China's largest petroleum and chemical company.
Sebaceous glands help the skin stay moist and protect it against external influences such as harsh weather, pollution, and microbial assaults: The oily or waxy matter that these microscopic, exocrine glands secrete – called sebum – lubricates and softens the skin and hair.
Cornelius Group Plc, a European distributor and manufacturer of speciality chemicals, ingredients and raw materials for the performance chemicals, personal care, health and nutrition markets, has announced the appointment of a new Group Finance Director.
A team of researchers from Queen’s University Belfast, led by Professor Ryan Donnelly, Professor of Pharmaceutical Technology are developing a new type of skin patch (microarray patch) that administers drugs directly into the bloodstream through thousands of individual “microneedles” which are being tested as a possible answer to the antibiotic resistance crisis.
3M has developed a “Find My Adhesive” product selector tool to help make medical adhesive selection a simpler process. The product selector tool will be available to demo at CES 2018 in Las Vegas from 9th – 12th January in the 3M booth within the Health & Wellness Marketplace.
Novartis has announced Kisqali® received US Food and Drug Administration (FDA) Breakthrough Therapy designation for the initial endocrine-based treatment of pre- or perimenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer in combination with tamoxifen or an aromatase inhibitor.
W. R. Grace & Co. has recently signed an agreement to acquire the Polyolefin Catalysts business of Albemarle Corporation for $416 million. The transaction is expected to close in the first quarter of 2018, subject to regulatory approvals and other customary closing conditions.